Sellas Life Sciences Shares Rise Amid Market Interest
Shares of Sellas Life Sciences rose 3.5 percent on the US market. Investors are tracking recent data on the development candidate SLS009.
Results for “pancreatic cancer”
1 story found.
1 story found.
Shares of Sellas Life Sciences rose 3.5 percent on the US market. Investors are tracking recent data on the development candidate SLS009.